Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 22 September 2022NewsHumanCOVID-19Medicines Biosimilar medicines can be interchanged 19 September 2022NewsHumanCorporateBiosimilars New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection 16 September 2022NewsHumanMedicines EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines 16 September 2022NewsHumanCOVID-19Vaccines Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval 12 September 2022NewsHumanCOVID-19Vaccines Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 September 2022 9 September 2022NewsVeterinaryMedicines ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines 6 September 2022NewsHumanCOVID-19Vaccines Accelerating Clinical Trials in the EU: publication of 2022-2026 workplan 2 September 2022NewsHumanClinical trials Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 August – 1 September 2022 2 September 2022NewsHumanPharmacovigilanceReferrals Review of pholcodine medicines started 2 September 2022NewsHumanMedicinesReferrals 1 … 36 37 38 39 40 Page 40 of 380 41 42 43 44 … 380
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 22 September 2022NewsHumanCOVID-19Medicines
New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection 16 September 2022NewsHumanMedicines
EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines 16 September 2022NewsHumanCOVID-19Vaccines
Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval 12 September 2022NewsHumanCOVID-19Vaccines
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 September 2022 9 September 2022NewsVeterinaryMedicines
ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines 6 September 2022NewsHumanCOVID-19Vaccines
Accelerating Clinical Trials in the EU: publication of 2022-2026 workplan 2 September 2022NewsHumanClinical trials
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 August – 1 September 2022 2 September 2022NewsHumanPharmacovigilanceReferrals